Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 11 to 20 of 413

Publication Record

Connections

Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events: From Mechanism to Patient Care.
Manouchehri A, Kanu E, Mauro MJ, Aday AW, Lindner JR, Moslehi J
(2020) Arterioscler Thromb Vasc Biol 40: 301-308
MeSH Terms: Cardiovascular Diseases, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Patient Care, Protein Kinase Inhibitors, Protein-Tyrosine Kinases
Added January 15, 2020
0 Communities
1 Members
0 Resources
6 MeSH Terms
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management.
Ala CK, Klein AL, Moslehi JJ
(2019) Curr Cardiol Rep 21: 156
MeSH Terms: Antineoplastic Agents, Immunological, Cardiotoxicity, Cardiovascular Diseases, Humans, Immunotherapy, Neoplasms, Pericarditis, Pericardium, Risk Factors
Added January 15, 2020
0 Communities
1 Members
0 Resources
9 MeSH Terms
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
Yeh ETH, Ewer MS, Moslehi J, Dlugosz-Danecka M, Banchs J, Chang HM, Minotti G
(2019) Semin Oncol 46: 397-402
MeSH Terms: Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Cardiotoxicity, Cardiovascular Diseases, DNA Topoisomerases, Type II, Humans, Medical Oncology, Molecular Targeted Therapy, Neoplasms, Poly-ADP-Ribose Binding Proteins
Added January 15, 2020
0 Communities
1 Members
0 Resources
10 MeSH Terms
Pulmonary Artery Acceleration Time in Young Adulthood and Cardiovascular Outcomes Later in Life: The Coronary Artery Risk Development in Young Adults Study.
Moreira HT, Vasconcellos HD, Ambale-Venkatesh B, Brittain EL, Nwabuo CC, Schmidt A, Lloyd-Jones DM, Carr JJ, Lewis CE, Jacobs DR, Gidding SS, Lima JAC
(2020) J Am Soc Echocardiogr 33: 82-89.e1
MeSH Terms: Adolescent, Adult, Cardiovascular Diseases, Coronary Artery Disease, Coronary Vessels, Echocardiography, Doppler, Female, Follow-Up Studies, Humans, Incidence, Male, Predictive Value of Tests, Prospective Studies, Pulmonary Artery, Risk Assessment, Risk Factors, United States, Young Adult
Added January 10, 2020
0 Communities
1 Members
0 Resources
18 MeSH Terms
Cardiovascular Toxicities Associated With Ibrutinib.
Salem JE, Manouchehri A, Bretagne M, Lebrun-Vignes B, Groarke JD, Johnson DB, Yang T, Reddy NM, Funck-Brentano C, Brown JR, Roden DM, Moslehi JJ
(2019) J Am Coll Cardiol 74: 1667-1678
MeSH Terms: Adenine, Adverse Drug Reaction Reporting Systems, Aged, Aged, 80 and over, Cardiovascular Diseases, Databases, Factual, Female, Humans, Male, Mortality, Pharmacovigilance, Piperidines, Pyrazoles, Pyrimidines, Retrospective Studies
Added November 12, 2019
0 Communities
2 Members
0 Resources
15 MeSH Terms
Impact of post-sepsis cardiovascular complications on mortality in sepsis survivors: a population-based study.
Wu MH, Tsou PY, Wang YH, Lee MG, Chao CCT, Lee WC, Lee SH, Hu JR, Wu JY, Chang SS, Lee CC
(2019) Crit Care 23: 293
MeSH Terms: Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Proportional Hazards Models, Risk Factors, Sepsis, Statistics, Nonparametric, Survivors, Taiwan
Added August 13, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
CNV Association of Diverse Clinical Phenotypes from eMERGE reveals novel disease biology underlying cardiovascular disease.
Glessner JT, Li J, Desai A, Palmer M, Kim D, Lucas AM, Chang X, Connolly JJ, Almoguera B, Harley JB, Jarvik GP, Ritchie MD, Sleiman PMA, Roden DM, Crosslin D, Hakonarson H
(2020) Int J Cardiol 298: 107-113
MeSH Terms: Aged, Aged, 80 and over, Body Mass Index, Cardiovascular Diseases, DNA Copy Number Variations, Electrocardiography, Electronic Health Records, Female, Genome-Wide Association Study, Genomics, Humans, Male, Middle Aged, Phenotype, Polymorphism, Single Nucleotide
Added March 24, 2020
0 Communities
1 Members
0 Resources
15 MeSH Terms
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.
Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, Zeiher A, Jaiswal S, Schulz C, Blankstein R, Bolton KL, Steensma D, Levine RL, Ebert BL
(2019) J Am Coll Cardiol 74: 567-577
MeSH Terms: Aging, Algorithms, Cardiovascular Diseases, Hematopoiesis, Hematopoietic Stem Cells, Humans, Mutation, Neoplasms, Risk Factors
Added November 12, 2019
0 Communities
1 Members
0 Resources
9 MeSH Terms
Endothelial-Dependent Vasomotor Dysfunction in Infants After Cardiopulmonary Bypass.
Krispinsky LT, Stark RJ, Parra DA, Luan L, Bichell DP, Pietsch JB, Lamb FS
(2020) Pediatr Crit Care Med 21: 42-49
MeSH Terms: Acetylcholine, Biomarkers, Cardiac Surgical Procedures, Cardiopulmonary Bypass, Cardiovascular Diseases, Child, Child, Preschool, Cytokines, Endothelium, Vascular, Heart Defects, Congenital, Humans, Infant, Microcirculation, Nitric Oxide, Pilot Projects, Postoperative Complications, Prospective Studies, Severity of Illness Index, Vascular Resistance, Vasodilator Agents, Vasomotor System
Added July 2, 2019
0 Communities
1 Members
0 Resources
21 MeSH Terms
Assessing cardiac safety in oncology drug development.
Seltzer JH, Gintant G, Amiri-Kordestani L, Singer J, Koplowitz LP, Moslehi JJ, Barac A, Yu AF
(2019) Am Heart J 214: 125-133
MeSH Terms: Antineoplastic Agents, Antineoplastic Agents, Immunological, Biomarkers, Cardiologists, Cardiovascular Diseases, Cell Line, Tumor, Clinical Trials as Topic, Data Collection, Drug Development, Drug Screening Assays, Antitumor, Heart, Humans, Immunotherapy, Medical Oncology, Research Design, Trastuzumab
Added November 12, 2019
0 Communities
1 Members
0 Resources
16 MeSH Terms